Bayer | BAYN - Sales Revenues


Bayer reported EUR10.87B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Air Liquide EUR 13.83B 7.04B Jun/2026
Akzo Nobel EUR 2.54B 52M Sep/2026
Alcon AG USD 2.78B 90M Jun/2026
Amarin USD 49.22M 451K Dec/2025
Arkema EUR 2.43B 250M Jun/2026
AstraZeneca USD 16.21B 830M Sep/2026
BASF EUR 16.36B 850M Sep/2026
Bayer EUR 10.87B 2.54B Jun/2026
Beiersdorf EUR 2.4B 50M Sep/2026
Corteva USD 6.38B 1.65B Jun/2026
Covestro EUR 6.73B 3.82B Jun/2026
Essilor EUR 14.82B 351M Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Genmab DKK 1.16B 259M Jun/2026
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.89B 480M Sep/2026
GRIFOLS EUR 1.87B 170M Jun/2026
Henkel EUR 10.35B 255M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Johnson Matthey GBP 1.28B 0 Mar/2026
Linde USD 8.78B 17M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.43B 300M Jun/2026
Novartis USD 14.52B 112M Sep/2026
Nutrien USD 14.87B 6.97B Jun/2026
Philips EUR 4.36B 450M Jun/2026
PPG Industries USD 4.4B 100M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 14.44B 2.49B Sep/2026
SAP EUR 10.27B 390M Sep/2026
Solvay EUR 1.03B 33M Jun/2026
UCB EUR 4.25B 764M Dec/2025
Umicore EUR 13.92B 3.24B Jun/2026
Vinci EUR 18.75B 2.47B Jun/2026